4//SEC Filing
Ramsay David Russ 4
Accession 0001209191-09-055903
CIK 0001347178other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 1:34 PM ET
Size
8.4 KB
Accession
0001209191-09-055903
Insider Transaction Report
Form 4
Ramsay David Russ
Director
Transactions
- Sale
Common Stock
2009-12-04$11.70/sh−100,000$1,170,000→ 662,500 total(indirect: See Footnotes) - Sale
Common Stock
2009-12-07$11.57/sh−100,000$1,157,000→ 562,500 total(indirect: See Footnotes)
Footnotes (2)
- [F1]Of such amount, 526,418 shares are owned directly by Care Capital Investments II, L.P. and indirectly by Care Capital II, LLC as general partner of Care Capital Investments II, L.P. Care Capital II, LLC disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that Care Capital II, LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. David Ramsay is one of the managing members of Care Capital II, LLC. Mr. Ramsay disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein, the amount of which cannot currently be determined.
- [F2]Of such amount, 36,082 shares of the reportable securities are owned directly by Care Capital Offshore Investments II, L.P. and indirectly by Care Capital II, LLC as general partner of Care Capital Offshore Investments II, L.P. Care Capital II, LLC disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that Care Capital II, LLC is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein. David Ramsay is one of the managing members of Care Capital II, LLC. Mr. Ramsay disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein, the amount of which cannot currently be determined.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001352876
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 1:34 PM ET
- Size
- 8.4 KB